Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026)
Aquestive Therapeutics (AQST) posted Times Interest Earned of 2.93 for Q2 2026, down 102.29% on a QoQ basis from 1.45 in Q1 2026, and up 28.34% year-over-year from 2.28 in Q2 2025.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026) Analysis & Trends
Aquestive Therapeutics has reported Times Interest Earned for 10 years, with the latest figure at 2.93 in Q2 2026.
- On a quarterly basis, Times Interest Earned rose 28.34% year-over-year to 2.93 in Q2 2026; TTM through Jun 2026 was 4.68, a 1.02% increase from a year earlier, with the FY2025 full-year figure at 6.39, down 130.94% from the prior year.
- Times Interest Earned was 2.93 for Q2 2026 at Aquestive Therapeutics, down from 1.45 in the prior quarter.
- The five-year high for Times Interest Earned was 0.02 in Q2 2024, with the low at 10.38 in Q4 2025.
- Average Times Interest Earned over 5 years is 4.25, with a median of 3.65 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned jumped 100.65% in 2024, then slumped 20754.23% in 2025.
- Over 5 years, Times Interest Earned stood at 6.49 in 2022, then jumped by 73.5% to 1.72 in 2023, then plunged by 183.98% to 4.89 in 2024, then tumbled by 112.46% to 10.38 in 2025, then soared by 71.78% to 2.93 in 2026.
- The last three Times Interest Earned figures came in at 2.93 (Q2 2026), 1.45 (Q1 2026), and 10.38 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -21.24 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 114.07 |
| 10 | Aquestive Therapeutics | 640.60 Mn | 542.11 Mn | 9.80 Mn | -2.93 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.93 |
| Mar 31, 2026 | -1.45 |
| Dec 31, 2025 | -10.38 |
| Sep 30, 2025 | -4.13 |
| Jun 30, 2025 | -4.09 |
| Mar 31, 2025 | -6.96 |
| Dec 31, 2024 | -4.89 |
| Sep 30, 2024 | -2.98 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | -3.22 |
| Dec 31, 2023 | -1.72 |
| Sep 30, 2023 | -1.89 |
| Jun 30, 2023 | -3.07 |
| Mar 31, 2023 | -3.21 |
| Dec 31, 2022 | -6.49 |
| Sep 30, 2022 | -5.37 |
| Jun 30, 2022 | -7.81 |
| Mar 31, 2022 | -6.02 |
| Dec 31, 2021 | -6.69 |
| Sep 30, 2021 | -2.86 |